Geyer S J, Schanberg S M
Life Sci. 1982 Mar 29;30(13):1087-100. doi: 10.1016/0024-3205(82)90529-x.
A 4 day half-life of dopamine beta-hydroxylase (DBH) was determined for rats injected IV with 125I-rat DBH from the slow exponential component of radioactivity appearing in plasma, urine, feces and combined urine and feces. Half-life estimates for 125I-rat DBH injected IV into WKY and SHR animals did not differ from Sprague Dawley (Zivic Miller) rats. Radioactivity declined in parallel in plasma, urine and feces following IV 125I-rat DBH administration and each radioactivity falloff curve could be resolved into two components. The slow phase of the decline of radioactivity excreted into urine and feces from which DBH half-life was calculated occurred between 5 and 25 days after 125I-rat DBH injection. The early fast phase which is associated with distribution of the exogenous protein in body fluids and tissues continued for approximately the first 140 hr after DBH injection. The distribution characteristics of IV administered active bovine DBH and 125I-rat DBH into the lymphatic system were examined. After active bovine DBH or 125I-rat DBH was injected IV into rats, active DBH or radioactivity, respectively, appeared in lymph fluid (thoracic duct) within 20 min; reached peak concentrations within 90 min, and thereafter, declined in parallel with the plasma concentration. The concentration of radioactivity in plasma and lymph fluid were found to be unequal at 9 hr but were equivalent 68-75 hrs after IV injection of 125I-rat DBH. Based on the amount of active DBH or radioactivity which accumulates in lymph fluid it is clear that a substantial amount (greater than 50%) of the DBH in blood circulates through the lymphatic channels. Analysis of parallel experiments with labelled serum albumin indicate that use of these methods to study plasma proteins do provide sensitive measures of biological half-life and lymphatic distribution characteristics. Specifically for DBH, the results of our study suggest that DBH normally circulates in plasma and lymph fluid with a biological half-life of 4 days.
通过分析静脉注射125I-大鼠多巴胺β-羟化酶(DBH)后血浆、尿液、粪便以及尿液和粪便混合物中放射性出现的缓慢指数成分,确定大鼠体内DBH的半衰期为4天。将125I-大鼠DBH静脉注射到WKY和SHR动物体内后的半衰期估计值与斯普拉格·道利(齐维克·米勒)大鼠没有差异。静脉注射125I-大鼠DBH后,血浆、尿液和粪便中的放射性平行下降,并且每条放射性衰减曲线都可以分解为两个成分。从尿液和粪便中排出的放射性下降的缓慢阶段(据此计算DBH半衰期)发生在125I-大鼠DBH注射后的5至25天之间。与外源性蛋白质在体液和组织中的分布相关的早期快速阶段在DBH注射后的大约前140小时持续。研究了静脉注射活性牛DBH和125I-大鼠DBH在淋巴系统中的分布特征。将活性牛DBH或125I-大鼠DBH静脉注射到大鼠体内后,活性DBH或放射性分别在20分钟内出现在淋巴液(胸导管)中;在90分钟内达到峰值浓度,此后,与血浆浓度平行下降。在静脉注射125I-大鼠DBH后9小时,发现血浆和淋巴液中的放射性浓度不相等,但在68 - 75小时后相等。根据在淋巴液中积累的活性DBH或放射性的量,很明显血液中相当一部分(超过50%)的DBH通过淋巴通道循环。对标记血清白蛋白的平行实验分析表明,使用这些方法研究血浆蛋白确实能提供生物半衰期和淋巴分布特征的灵敏测量。具体对于DBH,我们的研究结果表明DBH通常在血浆和淋巴液中循环,生物半衰期为4天。